Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Assessment of Patient Experience With Auto-Captioning Glasses in NF2-Related-Schwannomatosis

NCT: NCT07420751 · ACTIVE_NOT_RECRUITING

NCT IDNCT07420751
StatusACTIVE_NOT_RECRUITING
Start Date2026-02-19
Completion2026-12

Brief Summary

The goal of this clinical trial is to investigate the usability of auto-captioning glasses for adults diagnosed with NF2-related schwannomatosis and loss of hearing. The primary objective of the study is to determine the feasibility and acceptability of auto-captioning glasses in this population. Participants will be asked to: * Use the glasses at their discretion for 12 weeks * Report their feedback at 3 and 12 week timepoints via online surveys and remote qualitative interviews

Frequently Asked Questions

What is Assessment of Patient Experience With Auto-Captioning Glasses in NF2-Related-Schwannomatosis?

Assessment of Patient Experience With Auto-Captioning Glasses in NF2-Related-Schwannomatosis is a clinical trial registered under NCT07420751. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT07420751?

The current status of NCT07420751 (Assessment of Patient Experience With Auto-Captioning Glasses in NF2-Related-Schwannomatosis) is: ACTIVE_NOT_RECRUITING.

When did Assessment of Patient Experience With Auto-Captioning Glasses in NF2-Related-Schwannomatosis start?

Assessment of Patient Experience With Auto-Captioning Glasses in NF2-Related-Schwannomatosis started on 2026-02-19.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑